Why Is Moderna Stock Trading Higher On Tuesday?
Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On ...
Armed robbery in Revesby10h
Vaxxas Wins US Prize for Vaccine Patch Innovation
Clinical-stage Australian biotechnology company Vaxxas will receive $3.2 million from the US Biomedical Advanced Research and ...
FierceBiotech19h
HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
BioPharma Dive14h
Moderna gets $590M from US government for bird flu vaccine
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
Emergent BioSolutions’ Growth Potential: Ebola Vaccine Contract, Naloxone Expansion, and Monkeypox Study Drive Buy Rating
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Emergent Biosolutions (EBS – Research Report), with a ...
BioSpace16h
Moderna Nabs Another $590M from HHS for mRNA-Based Bird Flu Vaccines
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...
Emergent BioSolutions stock reaffirms buy rating on contract modification
H.C. Wainwright & Co. reaffirmed its Buy rating and $15.00 price target for Emergent BioSolutions stock (NYSE:EBS). The ...
cidrap.umn10h
HHS awards $590 million to Moderna to develop mRNA vaccines against pandemic flu threats
The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...
MyChesCo on MSN49m
HHS Allocates $211 Million to Advance mRNA Vaccine Technology
The U.S. Department of Health and Human Services (HHS) announced plans to invest $211 million in the Rapid Response ...
Managed Healthcare Executive10h
Moderna Awarded $590 Million for Bird Flu Vaccine Development
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...